NCT05566574 - A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Solid TumorMetastatic Cancer

Interventions

DRUG

RP-3500

RP-3500 on Days 1-5.

RADIATION

External Beam Radiotherapy (EBRT)

Palliative radiation therapy (4Gy x 5 fractions) to a metastatic site on Days 1-5

Trial Locations (7)

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

RECRUITING

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

RECRUITING

Memorial Sloan Kettering Cancer Center at Suffolk-Commack (All Protocol Activities), Commack

RECRUITING

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites), Basking Ridge

RECRUITING

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown

RECRUITING

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale